Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials

Published:2024-10 Issue: Volume:208 Page:107401
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Figlioli Gisella,Piovani Daniele,Peppas Spyros,Pugliese Nicola,Hassan Cesare,Repici Alessandro,Lleo Ana,Aghemo Alessio,Bonovas Stefanos

Funder

Ministry of Health

Publisher

Elsevier BV

Reference42 articles.

1. Glucagon-like peptide 1 in health and disease;Andersen;Nat. Rev. Endocrinol.,2018

2. Glucagon-like peptide-1 receptor agonists: the key to healthy weight loss maintenance?;Lehmann;Cardiovasc Res,2021

3. Incretin hormones: their role in health and disease;Nauck;Diabetes Obes. Metab.,2018

4. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes;Drucker;Lancet,2006

5. The role of incretins on insulin function and glucose homeostasis;Holst;Endocrinology,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP